Emerging applications of fluorescent nanocrystals quantum dots for micrometastases detection

Proteomics

Volumn 10, Issue 4, 2010, Pages 700-716

  Mahmoud, Wael ^a   Sukhanova, Alyona ^a,d   Oleinikov, Vladimir ^b   Rakovich, Yury P ^c   Donegan, John F ^c   Pluot, Michel ^a   Cohen, Jacques H M ^a   Volkov, Yuri ^c   Nabiev, Igor ^a,d,e  

^a UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

^b SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

^c TRINITY COLLEGE DUBLIN   (Ireland)

^d CIC NANOGUNE   (Spain)

^e BASQUE FOUNDATION FOR SCIENCE   (Spain)

Author keywords

Antibody; Breast cancer; Micrometastases; Multiplexing; Nanoproteomics; Quantum dot

Indexed keywords

CANCER ANTIBODY; NANOBEAD; NANOCRYSTAL; QUANTUM DOT;

CANCER CELL CULTURE; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; FLUORESCENCE MICROSCOPY; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; IMMUNOASSAY; LUNG ALVEOLUS CELL; MICROFLUIDIC ANALYSIS; MICROMETASTASIS; PHOTOCHEMISTRY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW;

BREAST NEOPLASMS; FEMALE; FLUORESCENT DYES; HUMANS; MICROSPHERES; NANOPARTICLES; NEOPLASM METASTASIS; NEOPLASTIC CELLS, CIRCULATING; PROTEOMICS; QUANTUM DOTS; TUMOR MARKERS, BIOLOGICAL;

EID: 77349099073     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200900540     Document Type: Review

References (118)

1. Vincent-Salomon, A., Bidard, F. C., Pierga, J. Y., Bone marrow micrometastasis in breast cancer: review of detection methods, prognostic impact and biological issues. J. Clin. Pathol. 2008, 61, 570-576.
2. Fehm, T., Braun, S., Muller, V., Janni, W. et al., A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation. Cancer 2006, 107, 885-892.
3. Nolé, F., Munzone, E., Zorzino, L., Minchella, I. et al., Variation of circulating tumor cell levels during treatment of metastatic breast cancer: prognostic and therapeutic implications. Ann. Oncol. 2008, 19, 891-897.
4. Pachmann, K., Dengler, R., Lobodasch, K., Frohlich, F. et al., An increase in cell number at completion of therapy may develop as an indicator of early relapse. J. Cancer Res. Clin. Oncol. 2008, 134, 59-65.
5. Wiedswang, G., Borgen, E., Karesen, R., Kvalheim, G. et al., Detection of isolated tumor cells and bone marrow is an independent prognostic factor in breast cancer. J. Clin. Oncol. 2003, 21, 3469-3478.
6. Witzig, T. E., Bossy, B., Kimlinger, T., Roche, P. C. et al., Detection of circulating cytokeratin-positive cells in the blood of breast cancer patients using immunomagnetic enrichment and digital microscopy. Clin. Cancer Res. 2002, 8, 1085-1091.
7. Schindlbeck, C., Stellwagen, J., Jeschke, U., Karsten, U. et al., Immunomagnetic enrichment of disseminated tumor cells in bone marrow and blood of breast cancer patients by the Thomsen-Friedenreich-Antigen. Clin. Exp. Metastasis 2008, 25, 233-240.
8. Moll, R., Franke, W. W., Schiller, D. L., Geiger, B. et al., The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982, 31, 11-24.
9. Athanassiadou, P., Grapsa, D., Recent advances in the detection of bone marrow micrometastases: a promising area for research or just another false hope? A review of the literature. Cancer Metastasis Rev. 2006, 25, 507-519.
10. Timar, J., Csuka, O., Orosz, Z., Jeney, A. et al., Molecular pathology of tumor metastasis: II. Molecular staging and differential diagnosis. Pathol. Oncol. Res. 2002, 8, 204-219.
11. Nabiev, I., Sukhanova, A., Artemyev, M., Oleinikov, V., Fluorescent colloidal particles as a detection tools in biotechnology systems, in: Elissari A. (Ed.), Colloidal Nanoparticles in Biotechnology, Wiley, London-Singapore-NY 2008, pp. 133-168.
12. Sukhanova, A., Nabiev, I., Fluorescent nanocrystal quantum dots as medical diagnostic tools. Exp. Opin. Med. Diagn. 2008, 2, 429-447.
13. Sukhanova, A., Susha, A. S., Bek, A., Mayilo, S. et al., Nanocrystal-encoded fluorescent microbeads for proteomics: antibody profiling and diagnostics of autoimmune diseases. Nano Lett. 2007, 7, 2322-2327.
14. Nie, S., Xing, Y., Kim, G. J., Simons, J. W., Nanotechnology applications in cancer. Annu. Rev. Biomed. Eng. 2007, 9, 257-288.
15. Nabiev, I., Mitchell, S., Davies, A., Williams, Y. et al., Nonfunctionalized nanocrystals can exploit a cell's active transport machinery delivering them to specific nuclear and cytoplasmic compartments. Nano Lett. 2007, 7, 3452-3461.
16. Zach, O., Lutz, D., Tumor cell detection in peripheral blood and bone marrow. Curr. Opin. Oncol. 2006, 18, 48-56.
17. Paterlini-Brechot, P., Benali, N. L., Circulating tumor cells (CTC) detection: clinical impact and future directions. Cancer Lett. 2007, 253, 180-204.
18. Wong, N. S., Kahn, H. J., Zhang, L., Oldfield, S. et al., Prognostic significance of circulating tumor cells enumerated after filtration enrichment in early and metastatic breast cancer patients. Breast Cancer Res. Treat. 2006, 99, 63-69.
19. Leon, S. A., Shapiro, B., Sklaroff, D. M., Yaros, M. J., Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res. 1977, 37, 646-650.
20. Huang, Z. H., Li, L. H., Hua, D., Quantitative analysis of plasma circulating DNA at diagnosis and during follow-up of breast cancer patients. Cancer Lett. 2006, 243, 64-70.
21. Catarino, R., Ferreira, M. M., Rodrigues, H., Coelho, A. et al., Quantification of free circulating tumor DNA as a diagnostic marker for breast cancer. DNA Cell Biol. 2008, 27, 415-421.
22. Silva, J. M., Dominguez, G., Villanueva, M. J., Gonzalez, R. et al., Aberrant DNA methylation of the p16INK4a gene in plasma DNA of breast cancer patients. Br. J. Cancer 1999, 80, 1262-1264.
23. Kobayashi, Y., Yoshinouchi, M., Tianqi, G., Nakamura, K., Presence of human papilloma virus DNA in pelvic lymph nodes can predict unexpected recurrence of cervical cancer in patients with histologically negative lymph nodes. Clin. Cancer Res. 1998, 4, 979-983.
24. Taback, B., Giuliano, A. E., Hansen, N. M., Hoon, D. S., Microsatellite alterations detected in the serum of early stage breast cancer patients. Ann. NY Acad. Sci. 2001, 945, 22-30.
25. Tada, M., Omata, M., Kawai, S., Saisho, H. et al., Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma. Cancer Res. 1993, 53, 2472-2474.
26. Muller, H. M., Widschwendter, A., Fiegl, H., Ivarsson, L. et al., DNA methylation in serum of breast cancer patients: an independent prognostic marker. Cancer Res. 2003, 63, 7641-7645.
27. Martinez-Galan, J., Torres, B., Del Moral, R., Munoz-Gamez, J. A. et al., Quantitative detection of methylated ESR1 and 14-3-3-sigma gene promoters in serum as candidate biomarkers for diagnosis of breast cancer and evaluation of treatment efficacy. Cancer Biol. Ther. 2008, 7, 958-965.
28. Ring, A., Smith, I. E., Dowsett, M., Circulating tumour cells in breast cancer. Lancet Oncol. 2004, 5, 79-88.
29. Stathopoulou, A., Vlachonicolis, I., Mavroudis, D., Perraki, M. et al., Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic significance. J. Clin. Oncol. 2002, 20, 3404-3412.
30. Stathopoulou, A., Mavroudis, D., Perraki, M., Apostolaki, S. et al., Molecular detection of cancer cells in the peripheral blood of patients with cancer: comparison of CK-19, CEA and maspin as detection markers. Anticancer Res. 2003, 23, 1883-1890.
31. Ntoulia, M., Stathopoulou, A., Ignatiadis, M., Malamos, N. et al., Detection of mammaglobin A-mRNA-positive circulating tumor cells in peripheral blood of patients with operable breast cancer with nested RT-PCR. Clin. Biochem. 2006, 39, 879-887.
32. Mercatali, L., Valenti, V., Calistri, D., Calpona, S. et al., RTPCR determination of maspin and mammaglobin B in peripheral blood of healthy donors and breast cancer patients. Ann. Oncol. 2006, 17, 424-428.
33. Felton, T., Harris, G. C., Pinder, S. E., Snead, D. R. et al., Identification of carcinoma cells in peripheral blood samples of patients with advanced breast carcinoma using RT-PCR amplification of CK7 and MUC-1. Breast 2004, 13, 35-41.
34. Gross, H. J., Verwer, B., Houck, D., Hoffman, R. A. et al., Model study detecting breast cancer cells in peripheral blood mononuclear cells at frequencies as low as 10(-7). Proc. Natl. Acad. Sci. USA 1995, 92, 537-541.
35. Riethdorf, S., Pantel, K., Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients: current state of detection and characterization. Pathobiology 2008, 75, 140-148.
36. Ballestrero, A., Garuti, A., Bertolotto, M., Rocco, I. et al., Effect of different cytokines on mammaglobin and maspin gene expression in normal leukocytes: possible relevance to the assays for the detection of micrometastatic breast cancer. Br. J. Cancer 2005, 92, 1948-1952.
37. Aerts, J., Wynendaele, W., Paridaens, R., Christiaens, M. R. et al., A real-time quantitative reverse transcriptase polymerase chain reaction (RT-PCR) to detect breast carcinoma cells in peripheral blood. Ann. Oncol. 2001, 12, 39-46.
38. Balducci, E., Azzarello, G., Valori, L., Toffolatti, L. et al., A new nested primer pair improves the specificity of CK-19 mRNA detection by RT-PCR in occult breast cancer cells. Int. J. Biol. Markers 2005, 20, 28-33.
39. Mitas, M., Mikhitarian, K., Walters, C., Baron, P. L., Quantitative real-time RT-PCR detection of breast cancer micrometastasis using a multigene marker panel. Int. J. Cancer 2001, 93, 162-171.
40. Xenidis, N., Perraki, M., Kafousi, M., Apostolaki, S., Predictive and prognostic value of peripheral blood cytokeratin-19 mRNA-positive cells detected by real-time polymerase chain reaction in node-negative breast cancer patients. J. Clin. Oncol. 2006, 24, 3756-3762.
41. Becker, S., Becker-Pergola, G., Fehm, T., Wallwiener, D., Time is an important factor when processing samples for the detection of disseminated tumor cells in blood/bone marrow by reverse transcription-PCR. Clin. Chem. 2004, 50, 785-786.
42. Alix-Panabières, C., Muller, V., Pantel, K., Current status in human breast cancer micrometastasis. Curr. Opin. Oncol. 2007, 19, 558-563.
43. Forus, A., Hoifodt, H. K., Overli, G. E., Myklebost, O. et al., Sensitive fluorescent in situ hybridization method for the characterisation of breast cancer cells in bone marrow aspirates. Mol. Pathol. 1999, 52, 68-74.
44. Somiari, S. B., Shriver, C. D., He, J., Parikh, K. et al., Global search for chromosomal abnormalities in infiltrating ductal carcinoma of the breast using array comparative genomic hybridization. Cancer Genet. Cytogenet. 2004, 155, 108-118.
45. Borgen, E., Beiske, K., Trachsel, S., Nesland, J. M. et al., Immunocytochemical detection of isolated epithelial cells in bone marrow: non-specific staining and contribution by plasma cells directly reactive to alkaline phosphatase. J. Pathol. 1998, 185, 427-434.
46. Borgen, E., Naume, B., Nesland, J. M., Nowels, K. W. et al., Use of automated microscopy for the detection of disseminated tumor cells in bone marrow samples. Cytometry 2001, 46, 215-221.
47. Lacroix, M., Significance, detection and markers of disseminated breast cancer cells. Endocr. Relat. Cancer 2006, 13, 1033-1067.
48. Borgen, E., Pantel, K., Schlimok, G., Muller, P. et al., A European interlaboratory testing of three well-known procedures for immunocytochemical detection of epithelial cells in bone marrow. Results from analysis of normal bone marrow. Cytometry B Clin. Cytom. 2006, 70, 400-409.
49. Alix-Panabières, C., Vendrell, J. P., Pelle, O., Rebillard, X. et al., Detection and characterization of putative metastatic precursor cells in cancer patients. Clin. Chem. 2007, 53, 537-539.
50. Cristofanilli, M., Budd, G. T., Ellis, M. J., Stopeck, A. et al., Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N. Engl. J. Med. 2004, 351, 781-791.
51. Riethdorf, S., Fritsche, H., Muller, V., Rau, T. et al., Detection of circulating tumor cells in peripheral blood of patients with breast cancer: a validation study of the CellSearch system. Clin. Cancer Res. 2007, 13, 920-928.
52. Nagrath, S., Sequist, L. V., Maheswaran, S., Bell, D. W. et al., Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 2007, 450, 1235-1239.
53. Lacroix, M., Significance, detection and markers of disseminated breast cancer cells. Endocr. Relat. Cancer 2006, 13, 1033-1067.
54. Wolfle, U., Muller, V., Pantel, K., Disseminated tumor cells in breast cancer: detection, characterization and clinical relevance. Future Oncol. 2006, 2, 553-561.
55. Schlimok, G., Funke, I., Holzmann, B., Gottlinger, G. et al., Micrometastatic cancer cells in bone marrow: in vitro detection with anti-cytokeratin and in vivo labeling with anti-17-1A monoclonal antibodies. Proc. Natl. Acad. Sci. USA 1987, 84, 8672-8676.
56. Pantel, K., Schlimok, G., Angstwurm, M., Weckermann, D. et al., Methodological analysis of immunocytochemical screening for disseminated epithelial tumor cells in bone marrow. J. Hematother. 1994, 3, 165-173.
57. Gerber, B., Krause, A., Muller, H., Richter, D., Simultaneous immunohistochemical detection of tumor cells in lymph nodes and bone marrow aspirates in breast cancer and its correlation with other prognostic factors. J. Clin. Oncol. 2001, 19, 960-971.
58. Braun, S., Pantel, K., Muller, P., Janni, W. et al., Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II or III breast cancer. N. Engl. J. Med. 2000, 342, 525-533.
59. Willipinski-Stapelfeldt, B., Riethdorf, S., Assmann, V., Woelfle, U. et al., Changes in cytoskeletal protein composition indicative of an epithelial-mesenchymal transition in human micrometastatic and primary breast carcinoma cells. Clin. Cancer Res. 2005, 11, 8006-8014.
60. Slamon, D. J., Goldolphin, W., Jones, L. A., Holt, J. A. et al., Studies of the HER-2/proto-oncogene in human breast cancer and ovarian cancer. Science 1989, 244, 707-712.
61. Solomayer, E. F., Becker, S., Pergola-Becker, G., Banchmann, R. et al., Comparison of HER2 status between primary tumor and disseminated tumor cells in primary breast cancer patients. Breast Cancer Res. Treat. 2006, 98, 179-184.
62. Wulfing, P., Borchard, J., Buerger, H., Heidl, S. et al., HER2-positive circulating tumor cells indicate poor clinical outcome in stage I to III breast cancer patients. Clin. Cancer Res. 2006, 12, 1715-1720.
63. Braun, S., Schlimok, G., Heumos, I., Schaller, G. et al., ErbB2 overexpression on occult metastatic cells in bone marrow predicts poor clinical outcome of stage I-III breast cancer patients. Cancer Res. 2001, 61, 1890-1895.
64. Braun, S., Hepp, F., Kentenich, C. R., Janni, W. et al., Monoclonal antibody therapy with edrecolomab in breast cancer patients: monitoring of elimination of disseminated cytokeratin-positive tumor cells in bone marrow. Clin. Cancer Res. 1999, 5, 3999-4004.
65. Fields, A. L., Keller, A., Schwartzberg, L., Bernard, S. et al., Adjuvant therapy with the monoclonal antibody edrecolomab plus fluorouracil-based therapy does not improve overall survival of patients with stage III colon cancer. J. Clin. Oncol. 2009, 27, 1941-1947.
66. Allard, W. J., Matera, J., Miller, M. C., Repollet, M. et al., Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with non-malignant diseases. Clin. Cancer Res. 2004, 10, 6897-6904.
67. Went, P. T. H., Lugli, A., Meier, S., Bundi, M. et al., Frequent EpCam protein expression in human carcinomas. Hum. Pathol. 2004, 35, 122-128.
68. Thurm, H., Ebel, S., Kentenich, C., Hemsen, A. et al., Rare expression of epithelial cell adhesion molecule on residual micrometastatic breast cancer cells after adjuvant chemotherapy. Clin. Cancer Res. 2003, 9, 2598-2604.
69. Thiery, J. P., Sleeman, J. P., Complex networks orchestrate epithelial-mesenchymal transitions. Nat. Rev. Mol. Cell Biol. 2006, 7, 131-142.
70. Smith, A. M., Ruan, G., Rhyner, M. N., Nie, S., Engineering luminescent quantum dots for in vivo molecular and cellular imaging. Ann. Biomed. Eng. 2006, 34, 3-14.
71. Sukhanova, A., Venteo, L., Devy, J., Artemyev, M. et al., Highly stable fluorescent nanocrystals as a novel class of labels for immunohistochemical analysis of paraffin-embedded tissue sections. Lab. Invest. 2002, 82, 1259-1261.
72. Jacobs, S., Subramaniam, V., Schonle, A., Jovin, T. M. et al., EFGP and DsRed expressing cultures of Escherichia coli imaged by confocal, two-photon and fluorescence lifetime microscopy. FEBS Lett. 2000, 479, 131-135.
73. Azzazy, H. M., Mansour, M. M., Kazmierczak, S. C., Nanodiagnostics: a new frontier for clinical laboratory medicine. Clin. Chem. 2006, 52, 1238-1246.
74. Aldana, J., Wang, Y. A., Peng, X., Photochemical instability of CdSe nanocrystals coated by hydrophilic thiols. J. Am. Chem. Soc. 2001, 123, 8844-8850.
75. Liu, W., Howarth, M., Greytak, A. B., Zheng, Y. et al., Compact biocompatible quantum dots functionalized for cellular imaging. J. Am. Chem. Soc. 2008, 130, 1274-1284.
76. Gao, X., Cui, Y., Levenson, R. M., Chung, L. W. et al., In vivo cancer targeting and imaging with semiconductor quantum dots. Nat. Biotechnol. 2004, 22, 969-976.
77. Dubertret, B., Skourides, P., Norris, D. J., Noireaux, V. et al., In vivo imaging of quantum dot encapsulated in phospholipids micelles. Science 2002, 298, 1759-1762.
78. Stsiapura, V., Sukhanova, A., Artemyev, A., Pluot, M. et al., Functionalized nanocrystal-tagged fluorescent polymer beads: synthesis, physicochemical characterization and immunolabeling application. Anal. Biochem. 2004, 334, 257-265.
79. Choi, H. S., Liu, W., Misra, P., Tanaka, E. et al., Renal clearance of quantum dots. Nat. Biotechnol. 2007, 25, 1165-1170.
80. Sukhanova, A., Devy, J., Venteo, L., Kaplan, H. et al., Biocompatible fluorescent nanocrystals for immunolabeling of membrane proteins and cells. Anal. Biochem. 2004, 324, 60-67.
81. Medintz, I. L., Clapp, A. R., Mattoussi, H., Goldman, E. R. et al., Self-assembled nanoscale biosensors based on quantum dot FRET donors. Nat. Mater. 2003, 2, 630-638.
82. Goldman, E. R., Anderson, G. P., Tran, P. T., Mattoussi, H. et al., Conjugation of luminescent quantum dots with antibodies using an engineered adaptor protein to provide new reagents for fluoroimmunoassays. Anal. Chem. 2002, 74, 841-847.
83. Clapp, A. R., Goldman, E. R., Mattoussi, H., Capping of CdSe-ZnS quantum dots with DHLA and subsequent conjugation with proteins. Nat. Protoc. 2006, 1, 1258-1266.
84. Mason, J. N., Tomlinson, I. D., Rosenthal, S. J., Blakeley, R. D., Labeling cell-surface proteins via antibody quantum dot streptavidin conjugates. Methods Mol. Biol. 2005, 303, 35-50.
85. Wu, X., Liu, H., Liu, J., Haley, K. N. et al., Immuno-fluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots. Nat. Biotechnol. 2003, 21, 41-46.
86. Michalet, X., Pinaud, F. F., Bentolila, L. A., Tsay, J. M. et al., Quantum dots for live cells, in vivo imaging, and diagnostics. Science 2005, 307, 538-544.
87. Dahan, M., Levi, S., Luccardini, C., Rostaing, P. et al., Diffusion dynamics of glycine receptors revealed by single-quantum dot tracking. Science 2003, 302, 442-445.
88. Sukhanova, A., Venteo, L., Cohen, J. H. M., Pluot, M. et al., Nano-biocaptures for research and diagnostics in inflammation diseases and cancer. Ann. Pharm. Fr. 2006, 64, 125-134.
89. Yezhelyev, M. V., Al-Hajj, A., Morris, C., Marcus, A. I. et al., In situ molecular profiling of breast cancer biomarkers with multicolor quantum dots. Adv. Mater. 2007, 19, 3146-3151.
90. Shi, C., Zhu, Y., Cerwinka, W. H., Zhau, H. E. et al., Quantum dots: emerging applications in urologic oncology. Urol. Oncol. 2008, 26, 86-92.
91. Xiao, Y., Telford, W. G., Ball, J. C., Locascio, L. E. et al., Semiconductor nanocrystal conjugates, FISH, and pH. Nat. Methods 2005, 2, 723.
92. Pathak, S., Choi, S. K., Arnheim, N., Thompson, M., Hydroxylated quantum dots as luminescent probes for in situ hybridization. J. Am. Chem. Soc. 2001, 123, 4103-4104.
93. Xu, H., Sha, M. Y., Wong, E. Y., Uphoff, J. et al., Multiplexed SNP genotyping using the Qbead system: A quantum dot-encoded microsphere-based assay. Nucleic Acids Res. 2003, 31, e43.
94. Gerion, D., Chen, F., Kannan, B., Fu, A. et al., Roomtemperature single-nucleotide polymorphism and multiallele DNA detection using fluorescent nanocrystals and microarrays. Anal. Chem. 2003, 75, 4766-4772.
95. Frangioni, J. V., In vivo near-infrared fluorescence imaging. Curr. Opin. Chem. Biol. 2003, 7, 626-634.
96. Kim, S., Lim, Y. T., Soltesz, E. G., De Grand, A. M. et al., Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping. Nat. Biotechnol. 2004, 22, 93-97.
97. Kaul, Z., Yaguchi, T., Kaul, S. C., Hirano, T. et al., Mortalin imaging in normal and cancer cells with quantum dot immunoconjugates. Cell Res. 2003, 13, 503-507.
98. Nida, D. L., Rahman, M. S., Carlson, K. D., Richards-Kortum, R. et al., Fluorescent nanocrystals for use in early cervical cancer detection. Gynecol. Oncol. 2005, 99, S89-S94.
99. Yu, X. F., Chen, L. D., Li, K. Y., Li, Y. et al., Immuno-fluorescence detection with quantum dot bioconjugates for hepatoma in vivo. J. Biomed. Opt. 2007, 12, 014008.
100. Gu, W., Pellegrino, T., Parak, W. J., Boudreau, R. et al., Quantum-dot-based cell motility assay. Sci. STKE 2005, 29, 15.
101. Jaiswal, J. K., Mattoussi, H., Mauro, J. M., Simon, S. M., Long-term multiple color imaging of live cells using quantum dot bioconjugates. Nat. Biotechnol. 2003, 21, 47-51.
102. Lidke, D. S., Nagy, P., Heintzmann, R., Arndt-Jovin, D. J. et al., Quantum dot ligands provide new insights into erbB/HER receptor-mediated signal transduction. Nat. Biotechnol. 2004, 22, 198-203.
103. Tada, H., Higuchi, H., Wanatabe, T. M., Ohuchi, N., In vivo real-time tracking of single quantum dots conjugated with monoclonal anti-HER2 antibody in tumors of mice. Cancer Res. 2007, 67, 1138-1144.
104. Tan, W. B., Jiang, S., Zhang, Y., Quantum dot based nanoparticles for targeted silencing of HER2/neu gene via RNA interference. Biomaterials 2007, 28, 1565-1571.
105. Gershon, D., Microarray technology: an array of opportunities. Nature 2002, 416, 885-891.
106. Fulton, R. J.,McDade, R. L., Smith, P. L., Kienker, L. J. et al., Advanced multiplexed analysis with the FlowMetrix system. Clin. Chem. 1997, 43, 1749-1756.
107. Meza, M. B., Bead-based HTS applications in drug discovery. Drug Discov. Today 2000, 5, 38-41.
108. Gratama, J. W., D'hautcourt, J. L., Mandy, F., Rothe, G. et al., Flow cytometric quantitation of immuno-fluorescence intensity: problems and perspectives. European Working Group on Clinical Cell Analysis. Cytometry 1998, 33, 166-178.
109. Resch-Genger, U., Grabolle, M., Cavaliere-Jaricot, S., Nitschke, R. et al., Quantum dots versus organic dyes as fluorescent labels. Nat. Methods 2008, 5, 763-775.
110. Sukhanova, A., Nabiev, I., Liquid-phase chips based on the fluorescent nanocrystal encoded microbeads for cancer diagnostics. Crit. Rev. Oncol. Hematol. 2008, 68, 39-59.
111. Han, M., Gao, X., Su, J. Z., Nie, S., Quantum-dot-tagged microbeads for multiplexed optical coding of biomolecules. Nat. Biotechnol. 2001, 19, 631-635.
112. Eastman, P. S., Ruan, W., Doctolero, M., Nuttall, R. et al., Qdot nanobarcodes for multiplexed gene expression analysis. Nano Lett. 2006, 6, 1059-1064.
113. Wilson, R., Spiller, D. G., Prior, I. A., Veltkamp, K. J. et al., A simple method for preparing spectrally encoded magnetic beads for multiplexed detection. ACS Nano 2007, 1, 487-493.
114. Guo, J., Yang, W. L., Wang, C. C., He, J. et al., Poly(Nisopropylacrylamide)-coated luminescent/magnetic silica microspheres: preparation, characterization, and biomedical applications. Chem. Mater. 2006, 18, 5554-5562.
115. Gao, X. H., Nie, S. M., Quantum dot-encoded mesoporous beads with high brightness and uniformity: rapid readout using flow cytometry. Anal. Chem. 2004, 76, 2406-2410.
116. Braun, S., Vogl, F. D., Naume, B., Janni, W. et al., A pooled analysis of bone marrow micrometastasis in international breast cancer. N. Engl. J. Med. 2005, 353, 793-802.
117. Pathak, S., Davidson, M. C., Silva, G. A., Characterization of the functional binding properties of antibody conjugated quantum dots. Nano Lett. 2007, 7, 1839-1845.
118. Jan, E., Byrne, S. J., Cuddihy, M., Davies, A. M. et al., High-content screening as a universal tool for fingerprinting of cytotoxicity of nanoparticles. ACS Nano 2008, 2, 928-938.